Celgene throws down millions to snag prime airtime for its psoriasis-fighter

Posted: July 6th, 2015  |  Company/topic: Celgene
As the market for psoriasis meds heats up, companies are throwing down some hefty chunks of change to snag airtime for their TV spots.

What You May Have Missed in Biotech: Celgene’s $1B Bet on Cancer Immunotherapy, and a New CF Drug

Posted: July 3rd, 2015  |  Company/topic: Celgene
One U.S. biotech company is celebrating Independence Day weekend with a fresh $1 billion in cash from a corporate partner, which it was able to secure without giving up its corporate independence. For…

Cancer Doc Failed to Report $138,000 Payment From Celgene As Probe Continues

Posted: July 1st, 2015  |  Company/topic: Celgene
July 2, 2015By Mark Terry, BioSpace.com...

Celgene, Juno collaborate on cancer and autoimmune diseases

Posted: July 1st, 2015  |  Company/topic: Celgene
Celgene, headquartered in Summit, N.J., and Seattle-based Juno Therapeutics have formed a global collaboration for the development and commercialization of immunotherapies. The two comp…